Directory



Tan Shao Weng Daniel

Associate Professor, SingHealth Duke-NUS Oncology Academic Clinical Programme

Duke-NUS Medical School

Bio

I am the Head of Department of the Division of Clinical Trials and Epidemiological Sciences, a Senior Consultant with the Division of Medical Oncology at National Cancer Centre Singapore (NCCS) and a senior clinician-scientist at Genome Institute of Singapore. My main area of interest is in thoracic, head and neck malignancies and drug development. I currently lead the Experimental Cancer Therapeutics Unit (ECRU) at NCCS and have been instrumental to growing it to one of the largest phase I units in Asia, running up to approximately 30-40 trials at any one time. I am also the Principal Investigator of the Cancer Therapeutics Research Laboratory at NCCS focused on developing representative patient-derived preclinical models to gain insights to drug response and resistance, complementing my role as the principal investigator for multiple biomarker-driven early phase clinical trials including first-in-human studies. I am the principal investigator for the National Medical Research Council Lung Cancer Large Collaborative Grant (2019-2023), and Chair of the Asian Thoracic Oncology Research Group, the latter set up as a platform to coordinate translational research and clinical trials in the region.

My research interests include rational application of “omics” technologies to unravel drug resistance in cancer therapeutics and accelerating the development of novel agents and biomarkers in the clinic. My research has been recognised through multiple local and international awards, including European Society of Medical Oncology (ESMO) Congress Travel Award, American Society of Clinical Oncology (ASCO) Merit Awards, ASCO Young Investigator Award as well as most recently being awarded the IASLC Daniel C. Idhe Lectureship Award in 2019, the latter in recognition of my work in the field of medical oncology and extensive contributions to the lung cancer arena. I also hold a SingHealth GCEO Outstanding Clinician-Researcher Award and am a two-time recipient of National Medical Research Council Clinician-Scientist Award. I have published widely in journals including Nature, Nature Medicine, Nature Genetics, The New England Journal of Medicine, The Lancet, The Lancet Oncology and Journal of Clinical Oncology. I was the past Chair of the Education Committee of the International Association for Study of Lung Cancer (IASLC) and have participated in the organising scientific committees and faculty member for multiple international conferences including World Conference on Lung Cancer (WCLC), ESMO and ASCO. In ESMO 2021, I am the track chair for translational research. I have been active in developing educational resources to enhance quality of lung cancer care globally. I serve as Associate Editor for the Journal of Thoracic Oncology, Journal of Clinical Oncology, as well as Scientific Editor for Cancer Discovery. I was the conference co-chair for WCLC, the flagship and largest interdisciplinary conference of the IASLC.

Education

Doctor of Philosophy

National University of Singapore, Singapore

Member, Royal Coll of Physicians

Royal College of Physicians, UK, United Kingdom

Bachelor of Medicine, Bachelor of Surgery

St Bartholomew's Hospital, United Kingdom

Bachelor of Science (Tumour Biology) Hons Class 1

University College London, University of London, United Kingdom

Browser not supported

Modern websites need modern browsers

To enjoy the full experience, please upgrade your browser

Try this browser